Segall Bryant & Hamill’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.54M | Hold |
29,330
| – | – | 0.04% | 390 |
|
|
2025
Q4 | $2.82M | Hold |
29,330
| – | – | 0.04% | 385 |
|
|
2025
Q3 | $2.79M | Hold |
29,330
| – | – | 0.04% | 379 |
|
|
2025
Q2 | $2.56M | Hold |
29,330
| – | – | 0.04% | 396 |
|
|
2025
Q1 | $2.64M | Hold |
29,330
| – | – | 0.04% | 395 |
|
|
2024
Q4 | $2.34M | Hold |
29,330
| – | – | 0.03% | 415 |
|
|
2024
Q3 | $2.64M | Buy |
+29,330
| New | +$2.47M | 0.04% | 408 |
|
|
2023
Q3 | – | Sell |
-7,540
| Closed | -$664K | – | 624 |
|
|
2023
Q2 | $664K | Buy |
7,540
+110
| +1% | +$9.47K | 0.01% | 531 |
|
|
2023
Q1 | $599K | Sell |
7,430
-4,614
| -38% | -$376K | 0.01% | 543 |
|
|
2022
Q4 | $936K | Sell |
12,044
-31,472
| -72% | -$2.55M | 0.01% | 495 |
|
|
2022
Q3 | $3.51M | Buy |
43,516
+350
| +0.8% | +$31.5K | 0.04% | 363 |
|
|
2022
Q2 | $3.88M | Sell |
43,166
-529
| -1% | -$53.6K | 0.04% | 359 |
|
|
2022
Q1 | $4.86M | Sell |
43,695
-2,077
| -5% | -$219K | 0.05% | 337 |
|
|
2021
Q4 | $4.73M | Sell |
45,772
-1,389
| -3% | -$161K | 0.04% | 327 |
|
|
2021
Q3 | $5.92M | Buy |
47,161
+1,187
| +3% | +$154K | 0.06% | 297 |
|
|
2021
Q2 | $5.7M | Buy |
45,974
+302
| +0.7% | +$37.9K | 0.06% | 304 |
|
|
2021
Q1 | $5.4M | Sell |
45,672
-464
| -1% | -$54.4K | 0.05% | 323 |
|
|
2020
Q4 | $5.42M | Sell |
46,136
-92
| -0.2% | -$10.1K | 0.06% | 283 |
|
|
2020
Q3 | $4.81M | Sell |
46,228
-3
| -0% | -$301 | 0.07% | 265 |
|
|
2020
Q2 | $4.25M | Sell |
46,231
-205
| -0.4% | -$19.7K | 0.07% | 237 |
|
|
2020
Q1 | $4.2M | Sell |
46,436
-731
| -2% | -$77.8K | 0.09% | 219 |
|
|
2019
Q4 | $5.35M | Sell |
47,167
-2,208
| -4% | -$242K | 0.08% | 239 |
|
|
2019
Q3 | $5.36M | Sell |
49,375
-1,196
| -2% | -$125K | 0.08% | 261 |
|
|
2019
Q2 | $4.92M | Buy |
50,571
+608
| +1% | +$55.5K | 0.07% | 280 |
|
|
2019
Q1 | $4.55M | Sell |
49,963
-924
| -2% | -$82.7K | 0.07% | 286 |
|
|
2018
Q4 | $4.63M | Buy |
50,887
+529
| +1% | +$49.4K | 0.08% | 270 |
|
|
2018
Q3 | $4.95M | Sell |
50,358
-2,055
| -4% | -$190K | 0.07% | 291 |
|
|
2018
Q2 | $4.49M | Sell |
52,413
-6,340
| -11% | -$530K | 0.07% | 312 |
|
|
2018
Q1 | $4.71M | Sell |
58,753
-7,421
| -11% | -$612K | 0.11% | 205 |
|
|
2017
Q4 | $5.34M | Sell |
66,174
-2,562
| -4% | -$205K | 0.12% | 190 |
|
|
2017
Q3 | $5.35M | Sell |
68,736
-210,216
| -75% | -$17.5M | 0.12% | 178 |
|
|
2017
Q2 | $24.8M | Sell |
278,952
-3,849
| -1% | -$325K | 0.58% | 48 |
|
|
2017
Q1 | $22.8M | Buy |
282,801
+13,549
| +5% | +$1.06M | 0.55% | 57 |
|
|
2016
Q4 | $19.2M | Buy |
269,252
+35,297
| +15% | +$2.77M | 0.48% | 68 |
|
|
2016
Q3 | $20.2M | Buy |
233,955
+24,597
| +12% | +$2.14M | 0.52% | 59 |
|
|
2016
Q2 | $18.2M | Buy |
209,358
+21,874
| +12% | +$1.77M | 0.48% | 64 |
|
|
2016
Q1 | $14.1M | Buy |
187,484
+1,813
| +1% | +$137K | 0.35% | 82 |
|
|
2015
Q4 | $14.3M | Sell |
185,671
-2,718
| -1% | -$205K | 0.34% | 87 |
|
|
2015
Q3 | $12.6M | Sell |
188,389
-238
| -0.1% | -$17.5K | 0.31% | 99 |
|
|
2015
Q2 | $14M | Buy |
188,627
+33,511
| +22% | +$2.56M | 0.31% | 100 |
|
|
2015
Q1 | $12.1M | Buy |
155,116
+148,731
| +2,329% | +$11.3M | 0.27% | 119 |
|
|
2014
Q4 | $461K | Hold |
6,385
| – | – | 0.01% | 431 |
|
|
2014
Q3 | $396K | Hold |
6,385
| – | – | 0.01% | 455 |
|
|
2014
Q2 | $407K | Sell |
6,385
-1,437
| -18% | -$87.3K | 0.01% | 462 |
|
|
2014
Q1 | $481K | Hold |
7,822
| – | – | 0.01% | 443 |
|
|
2013
Q4 | $449K | Hold |
7,822
| – | – | 0.01% | 458 |
|
|
2013
Q3 | $417K | Buy |
7,822
+720
| +10% | +$38.7K | 0.01% | 463 |
|
|
2013
Q2 | $366K | Buy |
+7,102
| New | +$351K | 0.01% | 448 |
|
Other funds holding MDT
VCM
VPM
Segall Bryant & Hamill's MDT Position: Q1 2026 in Review
Segall Bryant & Hamill held its Medtronic (MDT) position steady in Q1 2026 at 29,330 shares worth $2.54M. The position accounts for 0.04% of the portfolio, ranked #390.
Segall Bryant & Hamill first reported a position in MDT in Q2 2013 and has held it in 48 quarters since. The position peaked at $24.8M in Q2 2017. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Segall Bryant & Hamill held 29,330 shares of Medtronic worth $2.54M as of Q1 2026.
- Segall Bryant & Hamill left its Medtronic share count unchanged in Q1 2026.
- Medtronic made up 0.04% of Segall Bryant & Hamill's portfolio in Q1 2026, its #390 holding.
- Segall Bryant & Hamill first reported a position in Medtronic in Q2 2013 and has held it in 48 quarters since.
- Segall Bryant & Hamill's Medtronic position peaked at $24.8M in Q2 2017.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Segall Bryant & Hamill's 13F filing for Q1 2026, filed 15 May 2026.